Millennium Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-150,000
Closed -$2.09M 4262
2017
Q4
$2.09M Buy
+150,000
New +$2.03M ﹤0.01% 2253
2013
Q3
Sell
-60,200
Closed -$907K 3679
2013
Q2
$907K Buy
+60,200
New +$794K ﹤0.01% 2011

Millennium Management's MNTA Position: Q4 2020 in Review

Millennium Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 4,966,005 shares — an estimated $261K sold.

Millennium Management first reported a position in MNTA in Q2 2013 and held it in 26 quarters. The position peaked at $22.5M in Q2 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

  • Millennium Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
  • Millennium Management sold 4,966,005 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $261K.
  • Millennium Management first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2013 and held it in 26 quarters.
  • Millennium Management's Momenta Pharmaceuticals, Inc. position peaked at $22.5M in Q2 2020.
  • 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on Millennium Management's 13F filing for Q4 2020, filed 16 Feb 2021.